# Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

> **NCT06778447** · NA · RECRUITING · sponsor: **VIVEX Biologics, Inc.** · enrollment: 496 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Disc Degeneration
- Lumbar Discogenic Pain

## Interventions

- **OTHER:** VIA Disc NP
- **OTHER:** Sham

## Key facts

- **NCT ID:** NCT06778447
- **Lead sponsor:** VIVEX Biologics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2027-05
- **Final completion:** 2028-05
- **Target enrollment:** 496 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778447, "Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06778447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*